<DOC>
	<DOCNO>NCT02356250</DOCNO>
	<brief_summary>Rationale study : To try define PEF cirrhotic patient CSPH , maybe try find correlation HVPG result PEF result way result PEF test able predict patient CSPH ( yes ) . By , try develop portable office-based device produce immediate result non-invasive manner cirrhotic patient help evaluate prognosis patient noninvasive manner . Aim : The aim study try characterize peripheral endothelial function ( PEF ) patient cirrhosis CSPH . This evaluate measure PEF every patient evaluate HVPG level hemodynamic study .</brief_summary>
	<brief_title>A Pilot Study : Defining Peripheral Endothelial Function Portal Hypertensive Cirrhotic Patients</brief_title>
	<detailed_description>To try define PEF cirrhotic patient CSPH , maybe try find correlation HVPG result PEF result way result PEF test able predict patient CSPH ( yes ) . By , try develop portable office-based device produce immediate result non-invasive manner cirrhotic patient help evaluate prognosis patient noninvasive manner</detailed_description>
	<mesh_term>Hypertension , Portal</mesh_term>
	<criteria>1 . &gt; 18 year old ( Male/Female ) 75 year old 2 . Diagnosis cirrhosis : . By liver biopsy ii . Or strong suspicion cirrhosis accept criterion clinical diagnosis cirrhosis ( e.g . peripheral edema varix , palpable hard leave lobe liver , small right lobe span palpable splenomegaly ) , and/or radiological evidence cirrhosis ( abdominal US , CT , MRI , show nodular liver and/or portosystemic collateral portal vein patency and/or ascites and/or splenomegaly , and/or colloid shift colloidisotope liverspleen scan ) , and/or laboratory variable ( platelet &lt; 100,000/mm3 , albumin &lt; 3.5g/dL , INR &gt; 1.3 ) and/or presence esophageal varix ( without previous variceal bleed episode ) HVPGâ‰¥12mmHg previous testing , FIbroscan Fibrotest result show fibrosis stage 4. c. Has schedule hemodynamic study test . d. Patients Child Pugh score A high 1 . Patients already receive beta blocker 2 . Hepatocellular carcinoma 3 . Portal vein thrombosis 4 . Cholestatic liver disease 5 . Severe heart , pulmonary renal disease . 6 . Patients Ischemic heart disease 7 . Patients diabetes mellitus 8 . Any major surgery past 3 month . 9 . Patient recipient organ transplant 10 . Patient , base opinion investigator , enrol study . 11 . Patients unable unwilling sign inform consent 12 . Patients participate clinical trial evaluate experimental treatment procedure participate clinical trial past 3 month . 13 . Active smoking 14 . Uncontrolled hypertension Withdrawal criterion : 1 . Patient base opinion investigator withdrawl study due compliance 2 . Patient wish stop participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>liver biopsy f 4</keyword>
</DOC>